SCHEMBL14282201

SCHEMBL14282201

Cc1c(-n2ccnc2)cnn(-c2ccccc2)c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.49
▸ RAB9A P51151 6/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ LMNA P02545 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ HTT P42858 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ PAX8 Q06710 2/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ MITF O75030 1/20 0.42
▸ S1PR4 O95977 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ XBP1 P17861 1/20 0.42
▸ S1PR1 P21453 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ PPARG P37231 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14221370 0.84 ALDH1A1 (0.56) CYP3A4RAB9ASMN1; SMN2KMT2ANPC1
SCHEMBL14282208 0.76 RAB9A (0.53) CYP3A4RAB9ASMN1; SMN2LMNAKMT2A
SCHEMBL14220831 0.75 MCHR1 (0.59) CYP3A4SMN1; SMN2LMNAKMT2APOLB
SCHEMBL25968360 0.73 EGLN2 (0.40) CYP3A4LMNAKMT2AALDH1A1MAPT
SCHEMBL14282209 0.73 NOTUM (0.54) CYP3A4RAB9ASMN1; SMN2LMNAKMT2A
SCHEMBL14221276 0.73 IDO1 (0.59) CYP3A4RAB9ASMN1; SMN2KMT2APOLB
SCHEMBL11049861 0.73 ALDH1A1 (0.54) CYP3A4RAB9ASMN1; SMN2LMNAKMT2A
SCHEMBL14282337 0.71 NPBWR1 (0.46) CYP3A4SMN1; SMN2LMNAKMT2APOLB
SCHEMBL14282213 0.71 CYP17A1 (0.56) CYP3A4RAB9ASMN1; SMN2KMT2APOLB
SCHEMBL14282211 0.71 NPBWR1 (0.46) CYP3A4RAB9ASMN1; SMN2LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7320977-B2 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity BAYER HEALTHCARE AG (DE) 2008-01-22 — — US disclosed
Send feedback